The Global Membrane Oxygenation (ECMO) Machine Market size was reached USD 557 million in 2022 and is projected to experience a significant revenue compound annual growth rate (CAGR) of 4.9% during the forecast period. This growth is primarily attributed to the increasing prevalence of cardiovascular and respiratory disorders, which necessitate the use of advanced life support systems like ECMO machines. These devices serve as life-supporting tools, providing respiratory and cardiac support to patients with severe respiratory failure. By oxygenating the blood outside of the body, ECMO machines offer vital rest and repair time for the organs of individuals suffering from severe heart or lung failure. The growing elderly population and the rising number of patients in critical care further contribute to the demand for ECMO equipment.
Another driving factor behind the revenue growth of the ECMO machine market is the expanding utilization of these devices in neonatal and pediatric patients. Advanced life support technologies are crucial in aiding newborns and young patients with severe respiratory or cardiac failure, and ECMO machines offer an effective and secure means of life support in these cases. Moreover, manufacturers are investing in research and development projects to enhance the appearance and performance of ECMO devices, which is expected to fuel market growth. Improved safety features, such as pressure monitoring, flow alarms, and air embolism detection, are being incorporated into ECMO machines, enhancing patient safety and reducing the risk of adverse events.
Request Sample of These Report @
https://www.reportsanddata.com/download-free-sample/6287
The need for ECMO machines is growing due to the increasing prevalence of Acute Respiratory Distress Syndrome (ARDS) and Chronic Obstructive Pulmonary Disease (COPD). These severe illnesses require sophisticated life support systems like ECMO devices, which effectively support respiratory function and improve patient outcomes.
However, the high cost of ECMO devices and the scarcity of qualified personnel to operate these machines pose significant challenges that may restrain market revenue growth. Additionally, limited reimbursement policies for ECMO procedures may hinder market expansion.
The ECMO machine market is categorized based on various aspects. For instance, in terms of technology, the market includes Venovenous (V-V) ECMO, Venoarterial (V-A) ECMO, and Arteriovenous (A-V) ECMO. The V-V ECMO segment accounted for the largest revenue share in 2017, primarily due to its higher efficiency in supporting critically ill patients with respiratory failure. Hospitals represent the largest end-user segment, accounting for over 40% of the market revenue in 2017, driven by the high demand for advanced medical equipment and technology in healthcare facilities.
Regulations governing the sale and use of ECMO machines vary across different regions. In the United States, the U.S. Food and Drug Administration (FDA) regulates ECMO devices, while in the European Union (EU), the Medical Devices Directive (MDD) sets safety requirements for these devices. Manufacturers must obtain certification from the Japanese Ministry of Health, Labour and Welfare before selling ECMO machines in Japan. Additionally, global organizations like the World Bank and the Global Harmonization Task Force (GHTF) have established guidelines to ensure the quality, safety, and efficiency of ECMO machines.
Governments worldwide provide incentives, such as tax credits and subsidies, to promote the use of energy-efficient ECMO machines by manufacturers and healthcare providers.
In summary, the global ECMO machine market is witnessing significant growth driven by factors such as the rising prevalence of cardiovascular and respiratory disorders, increasing use in neonatal and pediatric patients, advancements in device design, and the need for advanced life support in critical care settings. However, challenges related to cost, personnel, and reimbursement policies need to be addressed for sustained market expansion.
To know Latest Insights of These Report @
https://www.reportsanddata.com/request-latest-insight/6287
Key Players Operating in ECMO Machine Market
- Getinge AB
- Medtronic plc.
- LivaNova PLC.
- Terumo Corporation
- Microport Scientific Corporation
- Nipro Corporation
- OriGen Biomedical
- Eurosets S.r.l.
- Spectrum Medical
- XENIOS AG
The global ECMO Machine Market has been segmented as follows:
Type Outlook (Revenue, USD Million; 2019-2032)
- Veno-arterial
- Veno-venous
- Arterio-venous
Application Outlook (Revenue, USD Million; 2019-2032)
- Respiratory
- Cardiac
- Extracorporeal Cardiopulmonary Resuscitation (ECPR)
- Others
End-Use Outlook (Revenue, USD Million; 2019-2032)
- Hospitals
- Ambulatory Surgical Centers (ASCs)
- Others
Regional Outlook (Revenue, USD Million; 2019-2032)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Sweden
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- A.E.
- South Africa
- Israel
- Rest of MEA
Request a customization of the report @
https://www.reportsanddata.com/request-customization-form/6287
Thank you for reading global ECMO Machine Market report. We also offer customized research reports as per client requirement. Kindly contact us to know more about the feature and our team will provide you a well-curated report in the stipulated time.
About Us:
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs | Insights
https://www.sinp.msu.ru/ru/ext_link?url=https://www.reportsanddata.com
https://content.iospress.com/LOGOUT?dest=https://www.reportsanddata.com
https://spotlight.radiopublic.com/images/thumbnail?url=https://www.reportsanddata.com
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Italiano
Russian
Romaian